X0306 4 2016-08-19 0 0001077183 NEOGENOMICS INC NEO 0001591950 ALBITAR MAHER 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 Chief Medical Officer Common Stock 63492 I Shares owned by Albitar Oncology Defined Benefit Plan Common Stock 2016-08-19 4 M 0 200000 1.43 A 263492 D Common Stock 2016-08-19 4 M 0 20000 3.45 A 283492 D Common Stock 2016-08-19 4 M 0 100000 4.78 A 383492 D Common Stock 2016-08-19 4 M 0 250000 1.43 A 633492 D Common Stock 2016-08-19 4 S 0 370000 8.23 D 263492 D Common Stock 2016-08-19 4 F 0 34625 8.26 D 228867 D Warrants (Right to Buy) 1.43 2016-08-19 4 X 0 200000 1.43 D 2014-05-09 2017-01-09 Common Stock 200000 0 D Stock Option (Right to Buy) 3.45 2016-08-19 4 X 0 20000 3.45 D 2015-03-05 2019-03-05 Common Stock 20000 10000 D Stock Option (Right to Buy) 4.78 2016-08-19 4 X 0 100000 4.78 D 2016-05-05 2020-05-05 Common Stock 100000 200000 D Stock Option (Right to Buy) 1.43 2016-08-19 4 X 0 250000 1.43 D 2013-01-09 2017-01-09 Common Stock 250000 0 D Stock Option (Right to Buy) 7.15 2017-04-20 2021-04-20 Common Stock 200000 200000 D Shares withheld by NeoGenomics, Inc. to satisfy the cost of shares in connection with the August 19, 2016 warrant exercise. Closing stock price on date of exercise, August 19, 2016. These warrants were issued to Dr. Albitar upon the start of his service to the Company and vest upon the achievement of certain milestones. On March 5, 2014 Dr. Albitar was granted 30,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 5, 2015 Dr. Albitar was granted 300,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. These stock options were granted upon the start of Dr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company. On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. /s/ Maher Albitar 2016-08-23